ES535124A0 - Un procedimiento para la produccion de una composicion de endotoxina destoxificada refinada. - Google Patents

Un procedimiento para la produccion de una composicion de endotoxina destoxificada refinada.

Info

Publication number
ES535124A0
ES535124A0 ES535124A ES535124A ES535124A0 ES 535124 A0 ES535124 A0 ES 535124A0 ES 535124 A ES535124 A ES 535124A ES 535124 A ES535124 A ES 535124A ES 535124 A0 ES535124 A0 ES 535124A0
Authority
ES
Spain
Prior art keywords
procedure
production
detoxified endotoxin
endotoxin composition
refined detoxified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535124A
Other languages
English (en)
Other versions
ES8606883A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ES8606883A1 publication Critical patent/ES8606883A1/es
Publication of ES535124A0 publication Critical patent/ES535124A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES535124A 1983-08-26 1984-08-14 Un procedimiento para la produccion de una composicion de endotoxina destoxificada refinada. Expired ES8606883A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52696783A 1983-08-26 1983-08-26

Publications (2)

Publication Number Publication Date
ES8606883A1 ES8606883A1 (es) 1986-05-01
ES535124A0 true ES535124A0 (es) 1986-05-01

Family

ID=24099553

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535124A Expired ES8606883A1 (es) 1983-08-26 1984-08-14 Un procedimiento para la produccion de una composicion de endotoxina destoxificada refinada.

Country Status (22)

Country Link
JP (1) JPS6072825A (es)
KR (1) KR880002223B1 (es)
AT (1) AT389228B (es)
AU (1) AU554039B2 (es)
BE (1) BE900377A (es)
CA (1) CA1225592A (es)
CH (1) CH660125A5 (es)
DE (2) DE3448164C2 (es)
DK (1) DK389384A (es)
ES (1) ES8606883A1 (es)
FI (1) FI843204A (es)
FR (1) FR2550945B1 (es)
GB (1) GB2147806B (es)
HU (1) HU191713B (es)
IL (1) IL72675A (es)
IN (1) IN157910B (es)
IT (1) IT1177974B (es)
NL (1) NL192326C (es)
NO (1) NO843243L (es)
NZ (1) NZ209233A (es)
SE (1) SE8404090L (es)
ZA (1) ZA846309B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629722A (en) * 1984-07-12 1986-12-16 Ribi Immunochem Research, Inc. Method of inhibiting the onset of acute radiation syndrome
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
DE10115310A1 (de) * 2001-03-28 2002-10-10 Nodar A Daniela Bakteriophagen-Präparation
KR100868443B1 (ko) * 2002-05-27 2008-11-11 주식회사 포스코 폭과 길이가 가변 조정되는 런치박스 제작장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2160326B1 (es) * 1971-11-19 1975-02-07 Anvar
BE793260A (fr) * 1971-12-24 1973-06-22 Pasteur Institut Agent immunostimulant, medicaments le contenant et procede de fabrication de cet agent immunostimulant
GB1516507A (en) * 1974-06-20 1978-07-05 Anvar Process for obtaining mycobacterial fractions with anti-tumor anti-viral and adjuvant activities and pharmaceutical compositions containing them
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product

Also Published As

Publication number Publication date
DE3448164C2 (es) 1987-06-25
FR2550945B1 (fr) 1988-09-16
GB2147806A (en) 1985-05-22
FI843204A0 (fi) 1984-08-14
KR880002223B1 (ko) 1988-10-20
IL72675A (en) 1988-04-29
AT389228B (de) 1989-11-10
NL192326B (nl) 1997-02-03
JPS6072825A (ja) 1985-04-24
HUT34887A (en) 1985-05-28
IT8448757A0 (it) 1984-08-24
FR2550945A1 (fr) 1985-03-01
KR850001696A (ko) 1985-04-01
DK389384D0 (da) 1984-08-13
CH660125A5 (de) 1987-03-31
CA1225592A (en) 1987-08-18
ATA273384A (de) 1989-04-15
DK389384A (da) 1985-02-27
SE8404090D0 (sv) 1984-08-14
ZA846309B (en) 1985-03-27
ES8606883A1 (es) 1986-05-01
AU3221584A (en) 1985-02-28
BE900377A (fr) 1985-02-18
AU554039B2 (en) 1986-08-07
DE3431058C2 (es) 1987-06-11
DE3431058A1 (de) 1985-03-07
NZ209233A (en) 1987-11-27
JPH0556326B2 (es) 1993-08-19
IN157910B (es) 1986-07-19
NL8402515A (nl) 1985-03-18
IL72675A0 (en) 1984-11-30
IT8448757A1 (it) 1986-02-24
FI843204A (fi) 1985-02-27
GB8420612D0 (en) 1984-09-19
IT1177974B (it) 1987-09-03
SE8404090L (sv) 1985-02-27
NL192326C (nl) 1997-06-04
GB2147806B (en) 1986-10-22
HU191713B (en) 1987-03-30
NO843243L (no) 1985-02-27

Similar Documents

Publication Publication Date Title
ES532228A0 (es) Un procedimiento para la preparacion de una composicion de aceite mineral-poliisobuteno-dioxido de silicio.
ES519469A0 (es) Procedimiento para la produccion de un preparado solido de fibrinogeno.
ES533753A0 (es) Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas.
ES537584A0 (es) Un procedimiento para la preparacion de injertos oftalmicos solidos.
ES531139A0 (es) Procedimiento para fabricar lunas.
ES533738A0 (es) Un procedimiento para la preparacion de ditiofosfatos metalicos.
ES510167A0 (es) Procedimiento para la produccion de n-acilo-polipeptidos.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES497825A0 (es) Un procedimiento para la produccion de una composicion de silicona.
ES529171A0 (es) Un procedimiento para la preparacion de una cefalosporina.
ES506992A0 (es) Un procedimiento para la preparacion de una macroliada.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES525138A0 (es) Un procedimiento para la preparacion de derivados de azetidina.
ES526268A0 (es) Un procedimiento para la produccion de un polimaleato.
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES504741A0 (es) Un procedimiento para la preparacion de una composicion esporicida de dialdehido-diol.
ES535124A0 (es) Un procedimiento para la produccion de una composicion de endotoxina destoxificada refinada.
ES543776A0 (es) Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoides
ES526050A0 (es) Un procedimiento para la produccion de glutation
ES538365A0 (es) Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas.
ES534066A0 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
ES540590A0 (es) Un procedimiento para la produccion de enol-esteres de oxi- cams.
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES530213A0 (es) Un procedimiento para la produccion de una 1, 4-dihalogenobutano-2, 3-diona
ES519108A0 (es) Procedimiento para la produccion de una 3,3-dialquil-o 3,3-dialquileno-indolina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050706